High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S

Oncogene. 1988 Sep;3(3):335-9.

Abstract

The c-myc gene is amplified in the SW 613-S cell line which was established from a human breast carcinoma. This line is heterogeneous: it contains cells with a high level of amplification and carrying the extra copies of the c-myc gene in double minute chromosomes (DMs) and cells with few c-myc genes integrated into chromosomes. Clones with different levels of amplification and different cytological localization of the c-myc copies were isolated from the SW 613-S cell population. Those with a high level of amplification and expression of the c-myc gene were highly tumorigenic in nude mice whereas those with a low level were not. Introduction of c-myc gene copies by transfection into the cells of several non-tumorigenic clones restored the tumorigenic phenotype. Our results indicate that a high level of amplification of the c-myc gene is a requirement for the tumorigenicity of SW 613-S cells in animals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology*
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / pathology
  • Female
  • Gene Amplification
  • Humans
  • Mice
  • Mice, Nude
  • Neoplasms, Experimental / etiology
  • Phenotype
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins c-myc
  • Proto-Oncogenes*
  • Transfection
  • Tumor Cells, Cultured / pathology*
  • Tumor Cells, Cultured / transplantation

Substances

  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-myc